These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2969910)

  • 1. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
    Rodger NW; Behme MT; Dupre J; Chamberlain MJ
    Clin Invest Med; 1988 Jun; 11(3):167-86. PubMed ID: 3042215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.
    Beck-Nielsen H; Olesen T; Mogensen CE; Richelsen B; Olsen HW; Ehlers N; Charles P; Sørensen NS
    Diabetes Res; 1990 Dec; 15(4):185-90. PubMed ID: 2132407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density lipoprotein subfractions during continuous insulin infusion therapy.
    Helve E
    Atherosclerosis; 1987 Apr; 64(2-3):173-80. PubMed ID: 3300667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
    Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE
    Metabolism; 1988 Jul; 37(7):640-4. PubMed ID: 3290622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Angeletti G; Cartechini MG; Brunetti P
    Diabetes Care; 1982; 5(5):457-65. PubMed ID: 7188333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes.
    Helve E; Koivisto VA; Lehtonen A; Pelkonen R; Huttunen JK; Nikkilä EA
    Acta Med Scand; 1987; 221(4):385-93. PubMed ID: 3300175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.
    Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ
    Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy.
    Cimino A; Valentini U; Rotondi A; Candrina R; Salvi A; Spandrio S; Radaeli E; Giustina G
    Acta Diabetol Lat; 1987; 24(3):193-8. PubMed ID: 3318256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1975-8. PubMed ID: 8626867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion.
    Massi Benedetti M; Home PD; Gill GV; Burrin JM; Noy GA; Alberti KG
    Diabetes Res Clin Pract; 1987; 3(6):307-17. PubMed ID: 3311678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study.
    Hermansen K; Møller A; Christensen CK; Christiansen JS; Schmitz O; Orskov H; Alberti KG; Mogensen CE
    Acta Endocrinol (Copenh); 1987 Mar; 114(3):433-9. PubMed ID: 3551432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission from insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, newly diagnosed diabetics: role of some hormonal and immunologic factors.
    Nardelli GM; Guastamacchia E; Di Paolo S; Lattanzi V; Ciampolillo A; Montedoro P; Giorgino R
    Acta Diabetol Lat; 1988; 25(4):343-50. PubMed ID: 3266701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.